AstraZeneca says antibody treatment failed in preventing COVID-19 in exposed patients

Anglo-Swedish drugmaker AstraZeneca (AZN.L) said on Tuesday a study of its monoclonal antibody treatment, AZD7442, did not meet the main goal of preventing symptomatic COVID-19 in people recently exposed to the novel coronavirus. The company said the participants in the trial were unvaccinated adults older than 18 years with confirmed […]